Analyst firms · Morgan Stanley · CME
Morgan Stanley CME price target and rating history
CME Group Inc. (CME) · Finance
Morgan Stanley rates CME Group Inc. (CME) Overweight with a $301 price target, as of its latest action on Apr 8, 2025. It has published 5 rating actions on CME since July 2021, including 1 upgrade and 0 downgrades. Across 5 firms with a CME price target in the last 12 months, the median target is $305.
- Current rating
- Overweight
- Price target
- $301
- Median target, all firms
- $305
- Actions on CME
- 5
Morgan Stanley price target on CME
Every Morgan Stanley rating on CME
- Apr 8, 2025
- Feb 11, 2022
- Oct 28, 2021
- Oct 8, 2021
- Jul 1, 2021
How other firms rate CME
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $301 | Oct 2, 2026 |
| Deutsche Bank | Hold | $270 | Aug 19, 2026 |
| Keefe, Bruyette & Woods | Outperform | $305 | Jun 18, 2026 |
| Rothschild & Co Redburn | Buy | $323 | Jun 11, 2026 |
| Erste Group | Hold | Jun 5, 2026 | |
| Argus Research | Hold | Mar 4, 2026 | |
| TD Cowen | Buy | $305 | Jan 14, 2026 |
Questions about Morgan Stanley and CME
- What is Morgan Stanley's price target for CME?
- Morgan Stanley's latest stated price target for CME Group Inc. (CME) is $301, from its action on Apr 8, 2025.
- What is Morgan Stanley's rating on CME?
- Morgan Stanley rates CME Overweight, a bullish rating, as of Apr 8, 2025.
- When did Morgan Stanley last change its view on CME?
- On Apr 8, 2025, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $301.
- How does Morgan Stanley's CME target compare with other analysts?
- Across 5 firms with a CME price target in the last 12 months, the median target is $305.
More CME rating histories
All Morgan Stanley ratingsCME news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.